Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.PRNewsWire • 09/16/24
Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and QatarAccesswire • 09/16/24
Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment ConferencePRNewsWire • 09/09/24
Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle EastPRNewsWire • 08/28/24
Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary SharesPRNewsWire • 08/23/24
Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary SharesPRNewsWire • 08/22/24
Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection KitsAccesswire • 08/21/24
Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024PRNewsWire • 04/25/24
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price DeficiencyPRNewsWire • 03/15/24
Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID PatientsPRNewsWire • 12/21/23
Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts WebinarPRNewsWire • 09/12/23
Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth MomentumPRNewsWire • 09/01/23
Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 BidPRNewsWire • 08/03/23
Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory FacilitiesPRNewsWire • 07/18/23